Nomura Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,000
Closed -$661K 2034
2024
Q4
$661K Buy
+5,000
New +$703K ﹤0.01% 1685
2024
Q2
Sell
-108,000
Closed -$14.8M 1867
2024
Q1
$14.8M Hold
108,000
0.04% 334
2023
Q4
$14.7M Buy
+108,000
New +$13.2M 0.04% 346
2018
Q1
Sell
-48,300
Closed -$5.16M 1543
2017
Q4
$5.16M Buy
+48,300
New +$5.16M 0.01% 613
2017
Q3
Sell
-48,300
Closed -$4.99M 1542
2017
Q2
$4.99M Buy
+48,300
New +$4.76M 0.01% 549
2017
Q1
Sell
-24,900
Closed -$2.21M 1425
2016
Q4
$2.21M Buy
+24,900
New +$2.27M 0.01% 825
2016
Q3
Sell
-74,700
Closed -$6.38M 1270
2016
Q2
$6.38M Buy
74,700
+49,800
+200% +$4.47M 0.02% 376
2016
Q1
$2.17M Buy
+24,900
New +$2.23M 0.01% 550

Other funds holding IBB

Nomura Holdings's IBB Position: Q2 2019 in Review

Nomura Holdings sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 127,291 shares — an estimated $14.2M sold.

Nomura Holdings first reported a position in IBB in Q2 2013 and held it in 17 quarters. The position peaked at $14.2M in Q1 2019. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • Nomura Holdings reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
  • Nomura Holdings sold 127,291 iShares Biotechnology ETF shares in Q2 2019, an estimated $14.2M.
  • Nomura Holdings first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 17 quarters.
  • Nomura Holdings's iShares Biotechnology ETF position peaked at $14.2M in Q1 2019.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Nomura Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.